Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 5397.00x is 1816% above its 4-year average of 281.71x, near the high end of its 4-year range (1.82x–5397.00x).
As of the fiscal period ended Friday, September 30, 2016. 122.83% above its 12-month average of 2422.03x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2016 (2016-09-30): 5397.00x.
INTEREST COVERAGE RATIO
5397.00x
INTEREST COVERAGE RATIO AVG TTM
2422.03x
INTEREST COVERAGE RATIO AVG 3Y
380.80x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+122.83%
CURRENT VS 3Y AVG
+1317.28%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
+128294.77%
vs the sector median at left
Inogen, Inc.
Market Cap
$161.12M
Interest Coverage Ratio
5397.00x
TTM Avg
2422.03x
3Y Avg
380.80x
5Y Avg
N/A
Market Cap
$158.25M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$155.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$154.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.95M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$171.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$151.32M
Interest Coverage Ratio
-29.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$150.59M
Interest Coverage Ratio
-7.96x
TTM Avg
23.57x
3Y Avg
23.57x
5Y Avg
23.57x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inogen, Inc. (INGN) | $161.12M | 5397.00x | 2422.03x | 380.80x | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $158.25M | -64.93x | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $155.04M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $154.76M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $154.72M | -5.64x | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $169.95M | -19.95x | 6.75x | 6.75x | 6.75x |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.61M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $151.32M | -29.32x | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $150.59M | -7.96x | 23.57x | 23.57x | 23.57x |
| Precision BioSciences, Inc. (DTIL)vs › | $173.34M | -36.67x | N/A | N/A | N/A |
Interest Coverage
5397.0x
Debt/Equity
0.09
Current Ratio
2.74
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2016-09-30 | 5397.00x |
| 2016-06-30 | 4009.50x |
| 2016-03-31 | 1092.33x |
| 2015-12-31 | 868.50x |
| 2015-09-30 | 742.80x |
| 2015-06-30 | 890.83x |
| 2015-03-31 | 359.71x |
| 2014-12-31 | 159.11x |
| 2014-09-30 | 34.30x |
| 2014-06-30 | 19.52x |
| 2014-03-31 | 11.65x |
| 2013-12-31 | 2.21x |
| 2013-09-30 | 7.84x |
| 2013-06-30 | 25.18x |
| 2013-03-31 | 6.09x |
| 2012-12-31 | 1.82x |
| 2012-09-30 | 3.75x |
